This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2019.
Company Filing History:
1 out of 29 
1 out of 5,383 
1 out of 1,853 
Years Active: 2019
Title: Catherine Muller: Innovator in Prostate Cancer Treatment
Introduction
Catherine Muller is a prominent inventor based in Toulouse, France. She has made significant contributions to the field of cancer research, particularly in the treatment and diagnosis of prostate cancer. Her innovative work has led to the development of a unique patent that addresses critical challenges in cancer therapy.
Latest Patents
Catherine Muller holds a patent titled "Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer." This invention focuses on an inhibitor of the expression of chemokine CCL7 or the receptor CCR3, or an inhibitor of the CCL7/CCR3 interaction. The application of this invention is aimed at preventing or treating the extension of prostate cancer outside the prostatic capsule in a subject. Additionally, the patent outlines a method for determining the degree of aggressiveness of a prostate cancer tumor by assessing the concentration or level of expression of the receptor CCR3 in tumor cell samples.
Career Highlights
Throughout her career, Catherine has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Centre Hospitalier Universitaire de Toulouse. Her dedication to research and innovation has positioned her as a key figure in the scientific community.
Collaborations
Catherine has collaborated with notable colleagues, including Victor Laurent and Philippe Valet. These partnerships have further enhanced her research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Catherine Muller is a trailblazer in the field of prostate cancer research, with her innovative patent paving the way for new treatment options. Her work exemplifies the impact of dedicated research on improving patient outcomes in cancer therapy.